- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02533245
Transplantoux Health Evaluation Study (THES)
Effect of an Exercise Training Intervention on Health-related Quality of Life and Psychosocial and Behavioral Variables in Adult Solid Organ Transplant Recipients: a Quasi-experimental Study Design
Study Overview
Status
Conditions
Detailed Description
During the last decades advances in solid organ transplantation, like e.g. organ preservation, surgical techniques and immunosuppressive treatment have contributed to improvements in postoperative survival. Thereby, solid organ transplantation (Tx) has moved from experimental treatment towards a clinical reality and a life-saving surgery, offering most patients a good long-term survival. However, further improvement in long-term survival remains a major challenge.
It is increasingly recognized that non-pharmacological interventions hold the potential to improve long-term outcomes in transplantation as evidence shows that health behavior has been independently associated with transplant outcome (e.g. physical activity, non-smoking, medication adherence). Furthermore, exercise training interventions show positive outcome in a number of populations and limited research in transplantation shows positive outcomes in view of exercise capacity, muscle strength, cardiopulmonary variables and body composition. However, there is a lack of research that evaluates exercise training interventions in view of patient reported outcomes (PROs) in transplant recipients.
In the University Hospitals of Leuven (Belgium) a project named 'Transplantoux' has been launched to enhance physical activity and exercise capacity in transplant recipients. Transplant recipients participate in the 'Transplantoux' exercise training intervention for 6-months with the ultimate goal to cycle or hike up the Mont Ventoux (France) (distance: 25.9 km, mean slope: 4.4%). Extending on a previous safety feasibility study in which we demonstrated that selected Transplant recipients can safely participate in an intense exercise program and that exercise capacity was significantly improved after training. The primary aim of the current study is to evaluate the short- and long-term effect of the 'Transplantoux' intervention in view of selected Patient Reported Outcomes (PROs), i.e. perceived health-related quality-of-life, depressive symptomatology, stress and well-being, physical activity, social contacts and social support, and barriers and motivators to exercise.
The Transplantoux Health Evaluation Study (THES) uses a quasi-experimental design with three convenience samples: 1) a convenience sample of solid organ transplant (Tx)-recipients participating in the Transplantoux exercise training intervention, 2) matched control sample of Tx-recipients not participating in the Transplantoux exercise intervention, and 3) and a convenience sample of healthy controls participating in the Transplantoux exercise intervention. Selected PROs will be assessed using validated self-reported questionnaire. Data collection will be performed at baseline, 3 months (in the middle of the training intervention), 6 months (immediately following the intervention), 9 months (3 months follow-up period) and 12 months (6 months follow-up period).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Evi Masschelein, PhD
- Phone Number: +3216372622
- Email: evi.masschelein@kuleuven.be
Study Contact Backup
- Name: Ceulemans
Study Locations
-
-
-
Leuven, Belgium, 3000
- Recruiting
- University Hospitals Leuven
-
Sub-Investigator:
- Laurens Ceulemans, MD
-
Sub-Investigator:
- Sabina De Geest, RN, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Tx exercise group:
Inclusion Criteria:
- Tx recipient (heart, lung, liver, kidney, pancreas or small bowel)
- Age between 18 - 70 years
- More than 1y post-transplant
Exclusion Criteria:
- Rejection last 6 months
- Severe co-morbidity
- Contra-indication for severe exercise (e.g. cardiovascular disease)
- Insufficient knowledge of Dutch language
Tx matched control group
Inclusion Criteria:
- Tx recipient (heart, lung, liver, kidney, pancreas or small bowel)
- Age between 18 - 70 years
- More than 1y post-transplant
Exclusion Criteria:
- Rejection last 6 months
- Insufficient knowledge of Dutch language
- Healthy exercise group:
Inclusion Criteria:
- Age between 18 - 70 years
Exclusion Criteria:
- Contra-indication for severe exercise
- Insufficient knowledge of Dutch language
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Tx exercise group
Convenience sample of solid organ transplant recipients (heart, kidney, lung, liver, pancreas, small bowel) participating in the Transplantoux exercise training intervention. Intervention:
|
Based on these results of the cardiopulmonary exercise test (CPET) on a cycle ergometer, an individualized training program (cycling/hiking) is prescribed by a physical therapist for 6 months (3x/week, ≥30min/session).
7 supervised group training sessions (cycling/hiking) are organized by a physiotherapist
Cycle or hike up the Mont Ventoux (25.7 km, average slope 4.5%)
|
|
No Intervention: Tx matched control group
Controls are retrieved from the Leuven University Hospital heart, kidney, lung, liver, pancreas, small bowel transplant database and matched (1:4 matching) based on type of transplant, gender, age and time since transplant.
|
|
|
Experimental: Healthy exercise group
Convenience sample of health care providers (e.g. doctor, paramedic or medical companion involved in care programs for organ Tx) and patient's family members and friends participating in the Transplantoux exercise training intervention. Intervention:
|
7 supervised group training sessions (cycling/hiking) are organized by a physiotherapist
Cycle or hike up the Mont Ventoux (25.7 km, average slope 4.5%)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in PROs (i.e. perceived quality of life, depressive symptomatology, stress and well-being, physical activity, and social contacts and support) in the Tx exercise group compared with Tx matched control group
Time Frame: baseline, 3, 6, 9 and 12 months
|
baseline, 3, 6, 9 and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in PROs (i.e. perceived quality of life, depressive symptomatology, stress and well-being, physical activity, and social contacts and support) in Tx exercise group compared with healthy exercise group
Time Frame: baseline, 3, 6, 9 and 12 months
|
baseline, 3, 6, 9 and 12 months
|
|
Compare PROs (i.e. perceived quality of life, depressive symptomatology, stress and well-being, physical activity, and social contacts and support) of the three groups with a representative sample of the Belgian population
Time Frame: baseline
|
baseline
|
|
Compare perceived barriers and motivators for physical exercise/activity in the three groups
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Diethard Monbaliu, MD, PhD, University Hospital Leuven, Abdominal Transplant Surgery
Study record dates
Study Major Dates
Study Start
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- THES1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Ziekenhuis Oost-LimburgRecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-LifeBelgium
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Istituto Ortopedico RizzoliUniversity of BolognaCompletedImprove Quality of LifeItaly
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia
-
Oslo University HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompletedHealth-Related Quality of LifeNorway
Clinical Trials on Home-based indiviualized exercise training program
-
Chang Gung Memorial HospitalCompletedModerate to Severe COPD Receiving Home Exercise TrainingTaiwan
-
University Hospital, AntwerpCompletedOxidative Stress | Exercise Training | Congenital Heart Disease | Coronary Microvascular Dysfunction | Congenital Heart Defect | Microvascular Dysfunction | Peripheral Microvascular DysfunctionBelgium
-
Bezmialem Vakif UniversityCompletedAdolescent Idiopathic ScoliosisTurkey
-
GO fit Lab- IngesportRecruiting
-
Mayo ClinicWithdrawn
-
University of Maryland, BaltimoreUniversity of SouthamptonCompletedStrokeUnited States
-
Eleftheria GiannouliRecruiting
-
University of SalamancaCompleted
-
Ross MasonNova Scotia Health AuthorityUnknownBladder Cancer | Urothelial Carcinoma
-
NYU Langone HealthCompletedStroke | Cerebral Vascular Accident (CVA)United States